Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
VEEV 
Veeva Systems Inc Class A (VEEV)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/11/2025: VEEV (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
32 Analysts rated it
Highly popular stock, broad analyst coverage, trusted insights, strong investor interest.
1 Year Target Price $292.4
1 Year Target Price $292.4
| 12 | Strong Buy |
| 7 | Buy |
| 11 | Hold |
| 1 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -11% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/11/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 46.02B USD | Price to earnings Ratio 59.85 | 1Y Target Price 292.4 |
Price to earnings Ratio 59.85 | 1Y Target Price 292.4 | ||
Volume (30-day avg) 32 | Beta 0.99 | 52 Weeks Range 177.41 - 291.69 | Updated Date 07/11/2025 |
52 Weeks Range 177.41 - 291.69 | Updated Date 07/11/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.61 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 27.34% | Operating Margin (TTM) 30.79% |
Management Effectiveness
Return on Assets (TTM) 6.9% | Return on Equity (TTM) 14.06% |
Valuation
Trailing PE 59.85 | Forward PE 37.31 | Enterprise Value 39092625997 | Price to Sales(TTM) 16.12 |
Enterprise Value 39092625997 | Price to Sales(TTM) 16.12 | ||
Enterprise Value to Revenue 13.69 | Enterprise Value to EBITDA 48.22 | Shares Outstanding 163412000 | Shares Floating 149924224 |
Shares Outstanding 163412000 | Shares Floating 149924224 | ||
Percent Insiders 8.55 | Percent Institutions 86.32 |
Upturn AI SWOT
Veeva Systems Inc Class A
Company Overview
History and Background
Veeva Systems was founded in 2007 by Peter Gassner and Matt Wallach. It initially focused on providing cloud-based software solutions for the life sciences industry. Veeva has grown rapidly through organic development and strategic acquisitions, becoming a leader in its niche.
Core Business Areas
- Veeva Commercial Cloud: A suite of applications designed to help life sciences companies manage their commercial operations, including CRM, content management, and multichannel marketing.
- Veeva Vault: A unified cloud platform for managing content and data across the product lifecycle, including clinical, regulatory, quality, and safety functions.
Leadership and Structure
Peter Gassner is the Founder and Chairman. Paul Shawah is the CEO. The company has a functional organizational structure with departments focused on product development, sales, marketing, and customer success.
Top Products and Market Share
Key Offerings
- Veeva CRM: A cloud-based CRM solution tailored for the life sciences industry. Veeva is the clear market leader with estimated market share over 60%. This is essential for pharma sales. Competitors include Salesforce Health Cloud and Microsoft Dynamics 365.
- Veeva Vault EDC: Electronic Data Capture for clinical trials, part of Veeva Vault Clinical Suite. Veeva has steadily gained market share. Competitors include Medidata Rave, Oracle Clinical One, and Clario EDC
- Veeva Vault RIM: Regulatory Information Management solution. Vault RIM helps companies manage regulatory submissions and product information. Veeva leads this space as well. Competitors include IQVIA RIM Smart, and Generis CARA
Market Dynamics
Industry Overview
The life sciences industry is highly regulated and requires specialized software solutions to manage its complex processes. The industry is undergoing digital transformation, driving demand for cloud-based solutions.
Positioning
Veeva is the leading provider of cloud-based software solutions for the global life sciences industry, offering a comprehensive suite of applications that address critical business needs.
Total Addressable Market (TAM)
The estimated TAM for Veeva's core markets exceeds $20 billion. Veeva is well-positioned to capture a significant portion of this market with its comprehensive product offerings and strong customer relationships.
Upturn SWOT Analysis
Strengths
- Dominant market position in life sciences
- Comprehensive product portfolio
- Strong customer relationships
- High customer retention rates
- Cloud-native architecture
Weaknesses
- High dependence on the life sciences industry
- Premium pricing may limit adoption by smaller companies
- Competition from larger tech companies like Salesforce and Oracle
Opportunities
- Expanding into new geographies and adjacent markets
- Developing new products and services to address evolving customer needs
- Leveraging artificial intelligence and machine learning to enhance its offerings
- Acquiring complementary technologies and companies
Threats
- Increased competition from established and emerging players
- Changes in regulatory requirements
- Economic downturn impacting life sciences spending
- Data security and privacy concerns
Competitors and Market Share
Key Competitors
- CRM (Salesforce)
- ORCL
- IQV
Competitive Landscape
Veeva benefits from specialization in the life sciences industry, which gives it a competitive edge over broader CRM and data management providers. It faces competition from established players such as Salesforce and Oracle, as well as specialized niche players.
Major Acquisitions
Crossix Solutions
- Year: 2019
- Acquisition Price (USD millions): 520
- Strategic Rationale: Expanded Veeva's data and analytics capabilities to provide better insights for pharmaceutical marketing.
Physician World
- Year: 2021
- Acquisition Price (USD millions): 250
- Strategic Rationale: Enhanced its medical customer relationship management (medical CRM) capabilities
Growth Trajectory and Initiatives
Historical Growth: Veeva has experienced strong revenue growth over the past several years, driven by increasing adoption of its cloud-based solutions.
Future Projections: Analysts project continued revenue growth for Veeva, driven by its strong market position and expanding product portfolio.
Recent Initiatives: Veeva continues to innovate new products and services. Veeva has expanded into adjacent markets such as consumer goods. Recent initiatives also include partnering with leading technology companies to enhance its offerings.
Summary
Veeva is a strong company with a dominant position in the life sciences software market. Its specialized focus, comprehensive product portfolio, and strong customer relationships are key strengths. However, Veeva must manage competition and dependence on the life sciences industry to maintain its growth trajectory.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (10-K, 10-Q)
- Analyst Reports
- Market Research Reports
- Company Website
- SEC.gov
Disclaimers:
This analysis is for informational purposes only and does not constitute investment advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Veeva Systems Inc Class A
Exchange NYSE | Headquaters Pleasanton, CA, United States | ||
IPO Launch date 2013-10-16 | Founder, CEO & Director Mr. Peter P. Gassner | ||
Sector Healthcare | Industry Health Information Services | Full time employees 7291 | Website https://www.veeva.com |
Full time employees 7291 | Website https://www.veeva.com | ||
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud consisting of Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; and Veeva RIM that provides regulatory information management capabilities; as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.